Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBWELL: Evaluating the Effectiveness of an Innovative Psychotherapeutic Intervention to Treat Postpartum Depression Among High-Risk Mothers

NCT06991166 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT06991166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06991166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBWELL: Evaluating the Effectiveness of an Innovative Psychotherapeutic Intervention to Treat Postpartum Depression Among High-Risk Mothers
Lead sponsor
Hackensack Meridian Health
Phase
Not applicable
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 1, 2028
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post partum depression